Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluating Tumor Hypoxia Radiosensitization Via Electron Paramagnetic Resonance Oxygen Imaging (EPROI)

Molecular Imaging and Biology(2023)10.1007/s11307-023-01855-0Source: DataRank Database

Evaluating Tumor Hypoxia Radiosensitization Via Electron Paramagnetic Resonance Oxygen Imaging (EPROI) is a research paper published in Molecular Imaging and Biology (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.52)OA: greenTopics (54)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Yvonne M. Mowery ORCID,Alex M. Bassil ORCID,Douglas Rouse ORCID,Nerissa T. Williams ORCID,Theresa Charity

Live enrichment

PubMed:37721686 PMC:PMC12135767 OpenAlex:https://openalex.org/W4386817609

NIDCR NIH HHS

Grant: K08 DE029887

NCI NIH HHS

Grant: R44 CA224840

NIH HHS

Grant: R41 OD026688

National Institutes of Health

Grant: 1R41OD026688-01A1

A portable multi-parametric optical spectroscopy device for key vascular and metabolic endpoints monitoring in small animals

National Institutes of Health

Grant: 2R44CA224840-02

Preclinical Oxygen Imager to Model Efficient Cancer Treatment

National Institutes of Health

Grant: 5K08DE029887-05

Employing Novel Primary Mouse Models of Head and Neck Cancer to Overcome Chemoradiation Resistance

FWCI

0.52

Citation Percentile

0.6%

Citation Trend

2024

2025

2026

greenLicense: Springer Nature TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12135767/pdf/nihms-2081587.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s11307-023-01855-0.pdf

publisherhttps://link.springer.com/article/10.1007/s11307-023-01855-0/fulltext.html

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12135767

Fields of Study

Cancer, Hypoxia, and MetabolismNanoplatforms for cancer theranosticsCancer Research and Treatments03 medical and health sciences0302 clinical medicineAnimalsTumor HypoxiaElectron Spin Resonance SpectroscopyOxygenCell Line, TumorFemaleMiceRadiation-Sensitizing AgentsSarcomaRadiation ToleranceMice, Inbred C57BL

MeSH Terms

Tumor HypoxiaAnimalsElectron Spin Resonance SpectroscopyFemaleMice, Inbred C57BLOxygenRadiation ToleranceRadiation-Sensitizing AgentsSarcomaCell Line, TumorMice

Keywords

RadioresistanceHypoxia (environmental)SarcomaTumor hypoxiaCancer researchMedicineMagnetic resonance imagingRadiation therapyPathologyNuclear medicineChemistryOxygenInternal medicineRadiologyRadiosensitizersDiffuse Reflectance Spectroscopy (Drs)Preclinical Tumor ModelsElectron Paramagnetic Resonance Oxygen Imaging (Eproi)Primary Tumor ModelMice, Inbred C57BLMiceRadiation-Sensitizing AgentsCell Line, TumorElectron Spin Resonance SpectroscopyAnimalsFemaleRadiation Tolerance

Sustainable Development Goals

SDG 0: Good health and well-being